References
- Elia J. Drug treatment for hyperactive children. Therapeutic guidelines. Drugs 1993;46:863-871. https://doi.org/10.2165/00003495-199346050-00006
- Anon. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 2002;41:26-49. https://doi.org/10.1097/00004583-200202001-00003
- Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, et al. ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry 2003;42:424-433. https://doi.org/10.1097/01.CHI.0000046814.95464.7D
- Kelly KL, Rapport MD, Dupaul GJ. Attention deficit disorder and methylphenidate-a multi-step analysis of dose-response effects on childrens cardiovascular functioning. Int Clin Psychopharmacol 1988;3:167-181. https://doi.org/10.1097/00004850-198804000-00007
- Solanto MV, Conners CK. A dose-response and time-action analysis of autonomic and behavioral-effects of methylphenidate in attention deficit disorder with hyperactivity. Psychophysiology 1982;19:658-667. https://doi.org/10.1111/j.1469-8986.1982.tb02519.x
- Tannock R, Schachar RJ, Carr RP, Logan GD. Dose-response effects of methylphenidate on academic-performance and overt behavior in hyperactive-children. Pediatrics 1989;84: 648-657.
- Ahmann PA, Waltonen SJ, Olson KA, Theye FW, Vanerem AJ, Laplant RJ. Placebo-controlled evaluation of ritalin side-effects. Pediatrics 1993;91:1101-1106.
- Barkley RA, Mcmurray MB, Edelbrock CS, Robbins K. Sideeffects of methylphenidate in children with attention-deficit hyperactivity disorder-a systemic, placebo-controlled evaluation. Pediatrics 1990;86:184-192.
- Klein R, Bessler A. Stimulant side effects in children. In: Lieberman J, ed. Adverse Effects of Psychotropic Drugs. New York: Guilford Press;1992. p.470-496.
- Firestone P, Musten LM, Pisterman S, Mercer J, Bennett S. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: A double-blind placebo-controlled study. J Child Adolesc Psychopharmacol 1998;8:13-25. https://doi.org/10.1089/cap.1998.8.13
- Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, et al. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics 2003;112:404-413. https://doi.org/10.1542/peds.112.5.e404
- Diamond IR, Tannock R, Schachar RJ. Response to methylphenidate in children with ADHD and comorbid anxiety. J Am Acad Child Adolesc Psychiatry 1999;38:402-409. https://doi.org/10.1097/00004583-199904000-00012
- Karabekiroglu K, Yazgan YM, Dedeoglu C. Can we predict short-term side effects of methylphenidate immediate-release? Int J Psychiaty Clin 2008;12:48-54. https://doi.org/10.1080/13651500701435954
- Cho SC, Shin MS. Diagnosis and assessment of child psychopathology. Seoul: Hakjisa;2006.
- Steele M, Jensen PS, Quinn DMP. Remission versus response as the goal of therapy in ADHD: A new standard for the field? Clin Ther 2006;28:1892-1908. https://doi.org/10.1016/j.clinthera.2006.11.006
- Kovacs M, Beck AT. An empirical- clinical approach toward a definition of childhood depression. depression in childhood: diagnosis', treatment and conceptual models. New York: Raven Press; 1977.
- Spielberger C. Preliminary manual for the Stait-Trait Anxiety Inventory for Children. Palo Alto: Consulting Psychologist Press; 1973.
- Cho SC, Choi JS. Development of the Korean Form of the State- Trait Anxiety Inventory for Children. Seoul J Psychiatry 1989;14: 150-157.
- Cho SC. A multi-center, open label study to evaluate safe and effective doses of OROS-MPH. Spring Meeting of the Korea Academy of Child and Adolescent Psychitry; 2004 May 14-15; Gyeongju, Korea. Seoul: Korea Academy of Child and Adolescent Psychietry;2004.
- Stein MA, Blondis TA, Schnitzler ER, OBrien T, Fishkin J, Blackwell B, et al. Methylphenidate dosing: twice daily versus three times daily. Pediatrics 1996;98:748-756.
- Rapport MD, Moffitt C. Attention deficit/hyperactivity disorder and methylphenidate - a review of height/weight, cardiovascular, and somatic complaint side effects. Clin Psychol Rev 2002;22: 1107-1131. https://doi.org/10.1016/S0272-7358(02)00129-0
- Fine S, Johnston C. Drug and placebo side-effects in methylphenidate- placebo trial for attention-deficit hyperactivity disorder. Child Psychiatry Hum Dev 1993;24:25-30. https://doi.org/10.1007/BF02353715
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-III. Washington DC: American Psychiatric Association;1980.
- Efron D, Jarman F, Barker M. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics 1997;100: 662-666. https://doi.org/10.1542/peds.100.4.662
- Ring A, Stein D, Barak Y, Teicher A, Hadjez J, Elizur A, et al. Sleep disturbances in children with attention-deficit/hyperactivity disorder: A comparative study with healthy siblings. J Learn Disabil 1998;31:572-578. https://doi.org/10.1177/002221949803100607
- Solanto MV. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 1998;94:127-152. https://doi.org/10.1016/S0166-4328(97)00175-7
- Findling RL, Short EJ, Manos MJ. Short-term cardiovascular effects of methylphenidate and Adderall. J Am Acad Child Adolesc Psychiatry 2001;40:525-529. https://doi.org/10.1097/00004583-200105000-00011
- Brown RT, Sexson SB. Effects of methylphenidate on cardiovascular- responses in attention deficit hyperactivity disordered adolescents. J Adolesc Health 1989;10:179-183. https://doi.org/10.1016/0197-0070(89)90229-5
- Brown RT, Wynne ME, Slimmer LW. Attention deficit disorder and the effect of methylphenidate on attention, behavioral, and cardiovascular functioning. J Clin Psychiatry 1984;45:473-476.
- Wilens T, McBurnett K, Stein M, Lerner M, Spencer T, Wolraich M. ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry 2005;44:1015-1023. https://doi.org/10.1097/01.chi.0000173291.28688.e7
- Steele M, Weiss M, Swanson J, Wang J, Prinzo RS, Binder CE. A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder. Can J Clin Pharmacol 2006;13:50-62.
Cited by
- The Current State of Clinical Studies for Herbal Medicine of Attention Deficit Hyperactivity Disorder (ADHD) -Focusing on Chinese Journals- vol.24, pp.1, 2013, https://doi.org/10.7231/jon.2013.24.1.001
- A Brief Replication Study Comparing Stimulants and Non-Stimulants for Attention-Deficit/Hyperactivity Disorder Treatment with a Focus on the Compliance, Efficacy, and Satisfaction vol.32, pp.1, 2010, https://doi.org/10.5765/jkacap.200024